Search

Search Constraints

You searched for: Author/Creator Barisic, Nina

Search Results

1. 255  SUNFISH part 2: risdiplam in type 2 and type 3 SMA. Issue 6 (27th May 2022)

2. Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth disease. Issue 5 (9th February 2022)

3. High association of MOG-IgG antibodies in children with bilateral optic neuritis. (July 2020)

4. Neonatal developmental and epileptic encephalopathy due to autosomal recessive variants in SLC13A5 gene. (16th October 2020)

5. Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly. (30th December 2014)

6. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Issue 1 (January 2022)

7. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Issue 1 (January 2022)

8. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Issue 1 (January 2022)

9. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial. Issue 12 (December 2022)

10. Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome. Issue 6 (13th November 2022)